Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Oral tofacitinib successfully treated total body hair loss in one patient.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

New compounds were found to help increase hair growth and decrease hair loss.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Tazarotene gel may be more effective for acne than adapalene gel.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.